RESTARTNCT05236062
Impact of Exercise on the Complications of Corticosteroids in Patients With GVHD: the RESTART Trial
At risk: Primary completion moved at least 5 months later.
Free. We email you which fields changed when ClinicalTrials.gov updates this record.
Record History
All 9 versions: 9 with changes below. See every version on ClinicalTrials.gov ↗
Notable Eligibility criteria expanded, about 17 words Show 6 more changesShow less
- Enrollment closed, study ongoing
- Primary completion pushed from Sep 9, 2026 to Feb 28, 2027
- Study completion date: Sep 9, 2027 to Sep 30, 2027
- Secondary endpoints: details revised at 14 of 14 entries
- Site details revised at 2 of 2 sites
- Study description expanded, about 2 words
- Notable Eligibility criteria revised
- Site contacts updated at 1 of 2 sites
- Notable Primary completion date: Jan 31, 2026 to Sep 9, 2026
- Study completion date: Oct 31, 2026 to Sep 9, 2027
- Site contacts updated at 1 of 2 sites
- Notable Primary completion date: Jan 31, 2025 to Jan 31, 2026
- Study completion date: Oct 31, 2025 to Oct 31, 2026
- Notable Primary completion date: Jan 31, 2024 to Jan 31, 2025
- Study completion date: Oct 31, 2024 to Oct 31, 2025
Show 3 earlier versionsHide 3 earlier versions
- Notable Primary completion date: Jan 31, 2023 to Jan 31, 2024
- Study completion date: Jan 31, 2024 to Oct 31, 2024
- Notable Trial status: Not Yet Recruiting to Recruiting
- Start date changed from estimate of Oct 2022 to Apr 14, 2022
- Site details revised at 2 of 2 sites
- Notable Start date: Jul 2022 to Oct 2022v2
- Study First Submitted
- Notable: the plan changed
Endpoints
Primary
Secondary (14)
Show 9 moreShow less
Arms and interventions
Home-based, virtually supervised via Zoom, 3x weekly for 12-weeks aerobic and resistance exercise program Participants will also undergo four testing visits across 6-month period. Tests will include four blood draws and three body composition scans via a dual-energy x-ray absorptiometry (DXA).
Home-based, 12-week stretching program only with participants asked not to change their activity behavior. Participants will also undergo four testing visits across 6-month period. Tests will include four blood draws and three body composition scans via a dual-energy x-ray absorptiometry (DXA).
Behavioral: Exercise, Attention control
Sites
2 sites in 1 country